Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pfizer’s $3.5B cost-cutting strategy hits Peapack site in New Jersey

By Brian Buntz | October 30, 2023

Pfizer logoAfter news emerged regarding Pfizer’s plans to close sites in North Carolina, the company is adding New Jersey to the list. The company expects its Peapack facility to cease operations in early 2024. 

A Worker Adjustment and Retraining Notification(WARN) Notice notes that 791 workers could potentially be cut from its Somerset County corporate office. The company hasn’t released an official tally, and notes that the “vast majority” of workers at the New Jersey site to be re-assigned to the company’s New York headquarters with another portion transitioning to the company’s site in Parsippany. 

Peapack closure part of Pfizer’s $3.5 billion cost-savings plan

To respond to weak demand for its COVID-19 therapies, Pfizer has announced a $3.5 billion cost-cutting drive, aiming to save at least that figure by the end of 2024. It will incur a one-time cost of $3 billion in the process.

The 595,000 Peapack site is situated on 130-acres in the Borough of Peapack and Gladstone in Somerset County, NJ. It comprises 10 buildings linked by covered canopies and a subterranean tunnel system. 

First built in 1979, Pharmacia & Upjohn acquired the property in 1998, which served as its corporate headquarters. Pfizer acquired it in 2003 following its acquisition of Pharmacia. 

Fueled in part by an influx of cash from its COVID-19 therapies, Pfizer went on a spending spree from May, 2019, to March, 2023. It acquired Therachon, Amplyx Pharmaceuticals, ResApp Health, Global Blood Therapeutics, and ICAgen. Its biggest recent acquisition, however, was its $43 billion proposed acquisition of Seagen, which European authorities recently approved. 

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE